Connect with us

Technology

Ceva, Inc. Announces First Quarter 2026 Financial Results

Published

on

Highlights strong licensing growth driven by integrated solutions and accelerating edge AI adoption

ROCKVILLE, Md., May 11, 2026 /PRNewswire/ — Ceva, Inc. (NASDAQ: CEVA), the leading licensor of silicon and software IP for the Smart Edge, today announced its financial results for the first quarter ended March 31, 2026.

First Quarter Highlights: *

Delivered total revenues of $27.0 million, up 11% year-over-yearLicensing and related revenues of $17.8 million, up 18% year-over-year and the highest in three yearsRoyalty revenues of $9.2 million, with smart edge royalties up 8% year-over-year, driven by record shipments in Wi-Fi, and strong contribution from cellular IoT, 5G infrastructure and automotive AISigned 14 IP licensing agreements, including several multi-technology engagements with existing customersSecured a major customer win for Bluetooth High Data Throughput (HDT) solution, including Ceva’s internally developed RF technology, demonstrating its system-level connectivity strategyExpanded customer engagements in 5G NTN and Ultra-Wideband, increasing value per designAI represented more than 20% of licensing and related revenues, with strong growth and key production milestones, including the Renesas R-Car V4H platform entering the 2026 Toyota RAV4, alongside a collaboration with NXP for its latest software-defined vehicle processors

*Unless otherwise stated, all comparisons are to first quarter 2025.

Amir Panush, Chief Executive Officer of Ceva, commented, “We delivered a strong start to 2026, highlighted by our highest licensing and related revenues in three years and continued momentum across our connectivity and AI portfolios. Importantly, this quarter reflects the successful execution of our strategy to expand beyond discrete IP into more integrated, system-level solutions. A major Bluetooth HDT licensing agreement, including RF, alongside our expansion in 5G NTN and Ultra-Wideband, demonstrates how we are increasing our value per design and deepening customer engagement. We also saw encouraging trends in royalties, with continued strength across our smart edge markets, partially offset by softness in smartphones.”

“In AI, our growth strategy and relentless focus on market-leading innovation are translating into production, with our technology integrated into leading automotive platforms and entering mass-volume production. With AI contributing over 20% of licensing and related revenues and a strong pipeline of engagements, we believe we are well positioned as the industry accelerates toward hybrid AI and the expansion of Physical AI at the edge.”

Business and Market Highlights
During the first quarter, Ceva signed 14 IP licensing agreements across connectivity, AI, and satellite communications, including several multi-technology engagements aligned with its strategy to deliver more integrated, system-level solutions.

The company secured a major full-stack Bluetooth HDT solution license, marking a key milestone in expanding value per design and increasing royalty contribution, while helping customers reduce integration complexity and accelerate time-to-market. Additional wins included a Wi-Fi 7 design targeting consumer IoT, a Wi-Fi 6 / Bluetooth combo engagement with a leading edge-AI SoC platform provider, and multiple Bluetooth and Wi-Fi agreements.

Ceva also expanded into new connectivity domains, introducing its PentaG-NTN platform and progressing a satellite customer engagement to a more integrated baseband solution. In Ultra-Wideband, the company launched its next-generation platform and secured a new customer as adoption accelerates across industrial and automotive applications.

In AI, Ceva continued to expand its footprint with multiple licensing agreements and achieved a key production milestone, with its AI DSP and accelerator deployed in the Renesas R-Car V4H platform, now entering production in the 2026 Toyota RAV4. The company also announced a collaboration with NXP for its latest software-defined vehicle processors. AI represented more than 20% of licensing and related revenues in the quarter, reflecting strong growth and increasing contribution.

Across its markets, Ceva continues to see strong demand in IoT and AI-driven applications, with record Wi-Fi shipments and significant growth in cellular IoT. These trends, together with the shift toward more integrated, system-level solutions and increasing adoption of Bluetooth and Wi-Fi combo chips, are driving higher value per device and reinforcing the company’s long-term royalty growth model.

Other first quarter financial data: *

GAAP gross margin was 86%, in line with last yearGAAP operating loss was $5.1 million, as compared to a GAAP operating loss of $4.4 millionGAAP net loss was $4.5 million, as compared to a GAAP net loss of $3.3 millionGAAP diluted loss per share was $0.16, as compared to GAAP diluted loss per share of $0.14Non-GAAP gross margin was 87%, in line with last yearNon-GAAP operating income was $0.5 million, as compared to non-GAAP operating income of $0.3 millionNon-GAAP net income and non-GAAP diluted earnings per share were $1.1 million and $0.04, respectively, compared with non-GAAP net income and non-GAAP diluted earnings per share of $1.4 million and $0.06, respectively

*Unless otherwise stated, all comparisons are to first quarter 2025.

Yaniv Arieli, Chief Financial Officer of Ceva, added, “Our first quarter results reflect strong licensing execution and the continued progression toward higher-value, multi-technology engagements. This shift is driving improved economics per deal and strengthening the long-term royalty potential of our business. We also continue to see encouraging trends across our diversified end markets, particularly in IoT and AI-driven applications. We continue to manage the impact of a weaker U.S. dollar and are implementing measures to partially offset the resulting expenses.”

Ceva Conference Call
On May 11, 2026, Ceva management will conduct a conference call at 8:30 a.m. Eastern Time to discuss the operating performance for the quarter.

The conference call will be available via the following dial in numbers:

U.S. Participants: Dial 1-844-435-0316 (Access Code: Ceva)International Participants: Dial +1-412-317-6365 (Access Code: Ceva)

The conference call will also be available live via webcast at the following link: https://app.webinar.net/N8PRLk4oljM. https://app.webinar.net/ePpLk12BRaDhttps://app.webinar.net/GvAklQElMmjPlease go to the web site at least fifteen minutes prior to the call to register.

For those who cannot access the live broadcast, a replay will be available by dialing +1 855-669-9658 or +1 412-317-0088 (access code: 4033535) from one hour after the end of the call until 9:00 a.m. (Eastern Time) on May 18, 2026. The replay will also be available at Ceva’s web site at www.ceva-ip.com.

Forward-Looking Statements
This press release contains forward-looking statements that involve risks and uncertainties, as well as assumptions that if they materialize or prove incorrect, could cause the results of Ceva to differ materially from those expressed or implied by such forward-looking statements and assumptions. Forward-looking statements include statements about Ceva’s positioning for future growth and to serve as a foundational technology provider for intelligent, connected devices, licensing agreement wins, future industry demand, our market position for the future and future growth in the demand of our products, our forecast of financial measures for the following quarter and 2026, our long term targets and underlying assumptions, our future investments, expectations about future market, the success of our strategies and agreements, visibility into future revenue streams, and Ceva’s focus on expense management and profitability improvement. The risks, uncertainties and assumptions that could cause differing Ceva results include: the effect of intense industry competition; the ability of Ceva’s technologies and products incorporating Ceva’s technologies to achieve market acceptance; Ceva’s ability to meet changing needs of end-users and evolving market demands; the lengthy sales cycle for IP and related solutions; Ceva’s ability to diversify royalty streams and license revenues; geopolitical risks and instability, including the impact of tariffs and other trade measures and potential disruptions related to ongoing conflicts in the Middle East; and general market conditions and other risks relating to Ceva’s business and industry, including, but not limited to, those that are described from time to time in our SEC filings. Ceva assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

About Ceva, Inc.
Ceva powers the Smart Edge, bridging the digital and physical worlds to bring AI-driven products to life. Our Ceva AI fabric portfolio of silicon and software IP enables devices to Connect, Sense, and Infer – the essential capabilities for the intelligent edge. From 5G, cellular IoT, Bluetooth, Wi-Fi, and UWB connectivity to scalable Edge AI NPUs, AI DSPs, sensor fusion processors and embedded software, Ceva provides the foundational IP for devices that connect, understand their environment, and act in real time.

With more than 21 billion devices shipped and trusted by 400+ customers worldwide, Ceva is the backbone of today’s most advanced smart edge products – from AI-infused wearables and IoT devices to autonomous vehicles and 5G infrastructure. Our differentiated solutions deliver seamless integration into existing design flows, total flexibility to combine solutions based on design needs and ultra–low–power performance in minimal silicon footprint, helping customers accelerate development, reduce risk, and bring innovative products to market faster. As technology evolves toward Physical AI, Ceva’s IP portfolio lays the foundation for systems that are always connected, contextually aware, and capable of intelligent, real-time decision-making.

Visit us at www.ceva-ip.com and follow us on LinkedIn, X, YouTube, Facebook, and Instagram.

 

CEVA, INC. AND ITS SUBSIDIARIES

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF LOSS – U.S. GAAP

U.S. dollars in thousands, except per share data

Three months ended

March 31,

2026

2025

Unaudited

Unaudited

Revenues:

Licensing and related revenues

$  17,820

$  15,042

Royalties

9,204

9,203

Total revenues

27,024

24,245

Cost of revenues

3,729

3,487

Gross profit

23,295

20,758

Operating expenses:

Research and development, net

19,837

17,609

Sales and marketing

3,766

3,449

General and administrative

4,660

3,933

Amortization of intangible assets

117

149

Total operating expenses

28,380

25,140

Operating loss

(5,085)

(4,382)

Financial income, net

1,877

2,100

Remeasurement of marketable equity securities

64

(54)

Loss before taxes on income

(3,144)

(2,336)

Income tax expense

1,315

991

Net loss

$  (4,459)

$  (3,327)

Basic and diluted net loss per share

$    (0.16)

$    (0.14)

Weighted-average shares used to compute net loss                                         

per share (in thousands):

Basic and diluted

27,678

23,764

 

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

U.S. dollars in thousands, except per share data

Three months ended

March 31,

2026

2025

Unaudited

Unaudited

GAAP net loss

$  (4,459)

$  (3,327)

Equity-based compensation expense included in cost of

revenues

182

159

Equity-based compensation expense included in research                               

and development expenses

2,863

2,466

Equity-based compensation expense included in sales

and marketing expenses

717

566

Equity-based compensation expense included in general

and administrative expenses

1,610

1,132

Amortization of intangible assets related to acquisition of

businesses

176

208

Costs associated with asset acquisition

61

144

Loss (income) associated with the remeasurement of

marketable equity securities

(64)

54

Non-GAAP net income

$  1,086

$  1,402

GAAP weighted-average number of Common Stock

used in computation of diluted net loss per share (in

thousands)

27,678

23,764

Weighted-average number of shares related to

outstanding stock-based awards (in thousands)

1,810

1,618

Weighted-average number of Common Stock used

in computation of diluted earnings per share, excluding the

above (in thousands)

29,488

25,382

GAAP diluted loss per share

$  (0.16)

$  (0.14)

Equity-based compensation expense

$   0.19

$   0.18

Amortization of intangible assets related to acquisition

of businesses 

$   0.01

$   0.01

Costs associated with asset acquisition

$   0.00

$   0.01

Non-GAAP diluted earnings per share

$   0.04

$   0.06

Three months ended

March 31,

2026

2025

Unaudited

Unaudited

GAAP operating loss

$  (5,085)

$  (4,382)

Equity-based compensation expense included in

cost of revenues

182

159

Equity-based compensation expense included in

research and development expenses

2,863

2,466

Equity-based compensation expense included in

sales and marketing expenses

717

566

Equity-based compensation expense included in

general and administrative expenses

1,610

1,132

Amortization of intangible assets related to acquisition

of businesses

176

208

Costs associated with asset acquisition

61

144

Total non-GAAP operating income

$      524

$      293

Three months ended

March 31,

2026

2025

Unaudited

Unaudited

GAAP gross profit

$  23,295

$  20,758

GAAP gross margin

86 %

86 %

Equity-based compensation expense included in

 cost of revenues

182

159

Amortization of intangible assets related to acquisition

of businesses

59

59

Total non-GAAP gross profit

23,536

20,976

Non-GAAP gross margin

87 %

87 %

Three months ended

March 31,

2026

2025

Unaudited

Unaudited

GAAP operating expenses

28,380

25,140

Equity-based compensation expense included in

research and development expenses

(2,863)

(2,466)

Equity-based compensation expense included in

sales and marketing expenses

(717)

(566)

Equity-based compensation expense included in

general and administrative expenses

(1,610)

(1,132)

Amortization of intangible assets related to acquisition

of businesses

(117)

(149)

Costs associated with asset acquisition

(61)

(144)

Total non-GAAP operating expenses

$  23,012

$  20,683

 

CEVA, INC. AND ITS SUBSIDIARIES

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

(U.S. dollars in thousands)

March 31,

December 31,

2026

2025 (*)

Unaudited

Unaudited

ASSETS

Current assets:

Cash and cash equivalents

$  21,367

$  40,586

Marketable securities and short-term bank deposits                                

194,326

181,397

Trade receivables, net

17,737

19,495

Unbilled receivables

31,135

29,860

Prepaid expenses and other current assets

16,297

13,498

Total current assets

280,862

284,836

Long-term assets:

Severance pay fund

7,225

7,530

Deferred tax assets, net

274

257

Property and equipment, net

9,010

7,054

Operating lease right-of-use assets

17,190

17,486

Investment in marketable equity securities

119

55

Goodwill

58,308

58,308

Intangible assets, net

868

1,044

Other long-term assets

14,370

11,686

Total assets

$ 388,226

$ 388,256

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Trade payables

$  2,388

$  2,418

Deferred revenues

2,968

3,496

Accrued expenses and other payables

19,224

21,026

Operating lease liabilities

2,794

1,743

Total current liabilities

27,374

28,683

Long-term liabilities:

     Accrued severance pay

7,428

7,690

Operating lease liabilities

14,083

14,388

Other accrued liabilities

1,158

1,037

Total liabilities

50,043

51,798

Stockholders’ equity:

Common stock

28

28

Additional paid in-capital

343,298

337,966

Treasury stock

0

(1,591)

Accumulated other comprehensive income (loss)

(660)

79

Accumulated deficit

(4,483)

(24)

Total stockholders’ equity

338,183

336,458

Total liabilities and stockholders’ equity

$ 388,226

$ 388,256

(*) Derived from audited financial statements.

The Company believes that the presentation of non-GAAP measures in the press release is useful to investors in analyzing the results for the quarters ended March 31, 2026, and 2025 because the exclusion of the applicable expenses may provide a meaningful analysis of the Company’s core operating results and comparison of quarterly results. Further, the Company believes it is useful for investors to understand how the expenses associated with the application of FASB ASC No. 718 are reflected in its statements of income. The reconciliation of financial measures should be reviewed in addition to and in conjunction with results presented in accordance with GAAP and are intended to provide additional insight into the Company’s operations that, when viewed with its GAAP results and the accompanying reconciliation, offer a more complete understanding of factors and trends affecting the Company’s business. The reconciliation of financial measures should not be viewed as a substitute for the Company’s reported GAAP results.

A reconciliation of non-GAAP guidance to the corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty of expenses that may be incurred in the future, although it is important to note that these factors could be material to the Company’s results computed in accordance with GAAP.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ceva-inc-announces-first-quarter-2026-financial-results-302767706.html

SOURCE Ceva, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Honoring Dr. J. Craig Venter’s Legacy, Human Longevity Launches Clinical-Grade $599 Whole Genome Sequencing Report with AI-Enhanced Insights for Proactive Disease Prevention

Published

on

By

SOUTH SAN FRANCISCO, Calif., May 11, 2026 /PRNewswire/ — Human Longevity, Inc. today announced the launch of its new Clinical-Grade $599 Whole Genome Sequencing Report, designed to bring advanced genomic medicine and AI-driven disease prevention to the general population.

Despite major advances in medicine, most diseases today are still identified only after symptoms appear — often limiting opportunities for earlier intervention and prevention. While genomic sequencing has generated vast amounts of biological data, one of healthcare’s biggest challenges has been translating that data into actionable health insights at scale.

Human Longevity’s new offering honors the legacy of Dr. J. Craig Venter, whose pioneering work helped decode the first human genome and transform modern medicine.

More than two decades ago, the Human Genome Project required over $3 billion and years of international effort to decode a single human genome. Today, Human Longevity is making a clinical grade genome sequencing broadly accessible with a comprehensive AI-enhanced genomic insight platform for just $599.

Dr. Venter long predicted that the human genome would play an increasingly important role in managing individual health and preventing disease. In recent years, a growing body of global scientific research has continued to validate this vision, demonstrating that genomics is becoming a foundational tool for predicting disease risk, guiding prevention strategies, and enabling more personalized healthcare.

“Dr. Venter believed that genomics would fundamentally transform medicine from reactive sick care to a proactive healthcare model,” said Wei-Wu He, Ph.D. Executive Chairman of Human Longevity Inc. “A decade ago, he founded Human Longevity to combine whole genome sequencing with advanced imaging, including Whole Body MRI, multi-omics data, longitudinal health data and AI, to help people live longer, healthier lives. We are proud to continue that mission by democratizing access to decades of work led by Human Longevity.”

Over the last decade, Human Longevity has invested more than $600 million building one of the world’s most comprehensive longitudinal health datasets. The company has collected and analyzed data from more than 10,000 individuals over a 10-year period, enabling the development of proprietary AI-driven insights focused on major age-related chronic diseases such as cardiovascular disease, cancer, and dementia.

The new Clinical-Grade Whole Genome Sequencing Insight Report is designed to provide individuals with actionable insights into inherited disease risks, carrier status, pharmacogenomics, longevity-associated traits, and personalized disease prevention opportunities.

“Our vision is simple,” added Dr. He. “Every individual should have access to their genome and AI-powered health insights. The genome is the foundation of modern preventive medicine.”

The new service will be available nationwide immediately through Human Longevity’s website.

For more information, visit:

Human Longevity Website

About Human Longevity, Inc.

Founded in 2013, Human Longevity, Inc. is a biotechnology company at the forefront of integrating genomics, artificial intelligence, and multimodal diagnostics to extend human healthspan founded by genomics pioneer J. Craig Venter. HLI delivers comprehensive, data-driven evaluations designed to identify and mitigate disease risk long before symptoms arise. The company is committed to redefining healthcare through AI-driven proactive diagnostics and personalized preventive care.

To learn more, visit http://www.humanlongevity.com/.

Media Contact:
media@humanlongevity.com
www.humanlongevity.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/honoring-dr-j-craig-venters-legacy-human-longevity-launches-clinical-grade-599-whole-genome-sequencing-report-with-ai-enhanced-insights-for-proactive-disease-prevention-302768424.html

SOURCE Human Longevity, Inc.

Continue Reading

Technology

DocuPet Launches AnimalsFirst Integration to Increase Pet Protection Nationwide

Published

on

By

SYRACUSE, N.Y., May 11, 2026 /PRNewswire/ — DocuPet is proud to announce a new strategic partnership with AnimalsFirst, marking the official launch of an integrated solution designed to connect animal welfare organizations directly with DocuPet’s National Pet Registry. This collaboration represents a significant milestone in DocuPet’s long-term vision to streamline shelter operations while expanding pet registration across North America.

For several years, DocuPet has invested in building a flexible, scalable software infrastructure capable of supporting integrations with leading shelter management systems. With the continued growth of the National Pet Registry and the National Animal Shelter Network (NASN), DocuPet is now positioned to activate these capabilities AnimalsFirst offers a highly customizable shelter management platform that supports adoptions, foster coordination, medical tracking, and field services for approximately 120 animal welfare organizations. Through this partnership, shelter partners using AnimalsFirst will be able to directly register adopters and their pets into the National Pet Registry through a streamlined backend integration.

Expanding Protection Through the National Pet Registry

At the core of this partnership is a shared commitment to increasing the number of pets enrolled in DocuPet’s National Pet Registry. Registration is a critical step in protecting pets, ensuring that accurate, up-to-date ownership information is readily accessible when a lost animal is found.

DocuPet’s HomeSafe® service plays a vital role in this effort. Each registered pet receives a free tag with a unique code linked to its secure online profile. When a lost pet is found, anyone can use the information on the tag to quickly initiate the reunification process. This immediate connection dramatically improves return-to-home rates and reduces the time pets spend in shelters.

Getting visible identification tags on pets is one of the simplest yet most effective ways to keep animals safe, and the success is multiplied when using DocuPet tags that offer superior reunification benefits. By increasing registration at the point of adoption and throughout the community, DocuPet and its partners are helping ensure more pets have the protection they need.

“We are thrilled to partner with AnimalsFirst and to be able to offer our registration program to shelters and pet owners utilizing their platform,” said Jackie Rose, CSO of DocuPet. “This enhanced and streamlined process will allow pet owners to easily register to receive the protection benefits of having a free pet identification tag, connected to our 24/7 lost pet recovery system.” 

Strengthening the Animal Welfare Ecosystem

This integration supports a broader, interconnected animal welfare ecosystem that includes pet owners, shelters, and animal control agencies. For pet owners, it provides peace of mind and an easy way to safeguard their animals. For shelters, it helps reduce overcrowding and administrative burden by increasing successful reunifications. For animal control officers, it offers a fast, reliable method to identify and return lost pets in the field.

By embedding registration opportunities directly into shelter workflows, DocuPet and AnimalsFirst are helping create a more proactive, efficient system; one that prioritizes prevention, accelerates reunification, and ultimately improves outcomes for animals and the communities that care for them.

This partnership underscores DocuPet’s commitment to leveraging technology to support animal welfare organizations, reduce administrative burden, and ensure more pets are protected through reliable identification and recovery services.

About DocuPet
DocuPet is the largest and fastest-growing pet registration and reunification platform in North America, providing official pet licensing services to more than 300 jurisdictions. DocuPet provides free lost pet services through HomeSafe®, and a unique product offering with an AI-powered pet tracker, designer pet tags, and other pet products/services. DocuPet is transforming how communities support animal welfare through inventive thinking and pioneering technology.

About AnimalsFirst
AnimalsFirst is a customizable shelter management software platform designed to support the operational needs of animal welfare organizations, including adoption management, foster coordination, medical tracking, and field services.

For more information, visit https://partnerships.docupet.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/docupet-launches-animalsfirst-integration-to-increase-pet-protection-nationwide-302767346.html

SOURCE DocuPet

Continue Reading

Technology

Boundary Labs Announces $2M Pre-Seed Led by Galaxy Ventures to Launch Verifiable Institutional Stablecoin, USBD

Published

on

By

The current stablecoin landscape often forces institutions to rely on trust in opaque centralized models, off-chain systems, and reserves. Boundary is solving this by introducing a protocol where verifiability is the core product feature.

NEW YORK, May 11, 2026 /PRNewswire/ — Boundary today announced the closing of a $2M USD pre-seed funding round led by Galaxy Ventures. Joining the round are a cohort of leading institutional finance partners and angels, including VCs BlackWood and FirstBlock Capital. The capital will accelerate the launch of USBD, a novel stablecoin protocol engineered specifically for financial and blockchain institutions and approved participants who require a new standard of on-chain verifiability in the >$300B stablecoin market.

“Trust but verify” is a phrase core to the on-chain industry as it champions a critical principle where institutions and retail should not just trust but also verify that what a protocol says and offers is real. Without real verifiable, there is no real trust. This is paramount to the industry’s security, stability, and scalability. However, the current stablecoin landscape often forces institutions to rely on trust rather than working with immediately verifiable products and reserves.

Boundary is solving this by introducing a protocol where verifiability is the core product feature. By providing institutional counterparties with clear technical documentation and a framework for verifiability of reserves and stablecoin performance, Boundary allows institutions to move on-chain with the certainty required for large-scale institutional stablecoin use cases like treasury management, regulated wrappers, and on-chain collateral.

The Boundary Protocol introduces a sophisticated structure designed for institutional compliance and operational clarity:

On-chain Verifiability: Unlike first generation stablecoins, USBD is built for continuous auditability of financial fundamentals, providing institutions with the data-driven confidence needed for professional participation and fiduciary products.Institutional-Only Onboarding: Access will be facilitated through a dedicated dApp designed for rigorous KYC and KYB workflows, ensuring only qualifying institutional participants enter the ecosystem in the institutional growth phase.Strategic Ecosystem Support: As a participant in several institutional partnerships, soon to be announced, and having completed a security audit by Cyfrin, Boundary has quickly positioned itself as the project with the leading technology to ensure protocol integrity.

“Boundary represents a proposition that speaks the language of institutional finance,” said Matthew Mezger, Co-Founder of Boundary. “By prioritizing verifiability and partnering with Galaxy Ventures, we are providing the professional-grade infrastructure necessary to reach our initial milestone of $100M in Total Value Locked (TVL) in 2026”.

Following today’s announcement, and building on a successful proof-of-concept for the protocol’s self-funding capability through derisked decentralized market participation, Boundary will initiate a Private Placement Campaign to onboard initial institutional partners.

“Institutional adoption of stablecoins is not only well underway but already proving its value in real-world use cases. With a long runway of growth still ahead, unlocking the full potential of stablecoins requires infrastructure that is not just secure, but inherently verifiable,” said Danny Slutsky, Investor at Galaxy Ventures. “Boundary’s focus on professional participants and its goal to bridge the gap between traditional finance and blockchain makes it a promising player in growing the stablecoin market.”

About Boundary: Boundary Labs is mandated by the Boundary Foundation and Boundary OpCo to lead the design, development, and commercial representation of the Boundary project. Based in New York City, the firm provides financial institutions and professional participants with secure, verifiable access to the USBD stablecoin and the broader Boundary Protocol ecosystem. For more information, visit https://boundary.finance/.

View original content to download multimedia:https://www.prnewswire.com/news-releases/boundary-labs-announces-2m-pre-seed-led-by-galaxy-ventures-to-launch-verifiable-institutional-stablecoin-usbd-302767720.html

SOURCE Boundary Labs International, Inc.

Continue Reading

Trending